Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial

BACKGROUND: The PIROUETTE (PIRfenidOne in patients with heart failUre and preserved lEfT venTricular Ejection fraction) trial is designed to evaluate the efficacy and safety of the anti-fibrotic pirfenidone in patients with chronic heart failure and preserved ejection fraction (HFpEF) and myocardial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Drugs Ther
Main Authors: Lewis, Gavin A., Schelbert, Erik B., Naish, Josephine H., Bedson, Emma, Dodd, Susanna, Eccleson, Helen, Clayton, Dannii, Jimenez, Beatriz Duran, McDonagh, Theresa, Williams, Simon G., Cooper, Anne, Cunnington, Colin, Ahmed, Fozia Zahir, Viswesvaraiah, Rajavarma, Russell, Stuart, Neubauer, Stefan, Williamson, Paula R., Miller, Christopher A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689029/
https://ncbi.nlm.nih.gov/pubmed/31069575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-019-06876-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados